Skip to main content
SpringerLink
Log in

Tropenophthalmologie—Prävention und Therapie

„Vision 2020—das Recht auf Sehen“

Tropical ophthalmology—prevention and therapy

“Vision 2020—the right to sight”

  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Weltweit sind 45 Mio. Menschen blind, 180 Mio. leiden an Sehbehinderung; 90% aller blinden Menschen leben in der „Dritten Welt“; 80% der Blindheit auf dieser Erde wären vermeidbar. Der volkswirtschaftliche Schaden durch Blindheit betrug weltweit rund 19 Milliarden US$ für das Jahr 2000. Die wichtigsten Herausforderungen der WHO-Kampagne „Vision 2020—the right to sight“ sind, die Zahl der Kataraktoperationen zu erhöhen und Augenerkrankungen wie Trachom, Onchozerkose sowie die Ursachen der Kinderblindheit zu bekämpfen. Bis zum Jahr 2020 sollen insgesamt 100 Mio. Menschen vor der Erblindung bewahrt werden.

Abstract

Worldwide 45 million people are blind, 180 million people are visually handicapped, 90% of all blind people are living in developing countries and 80% of blindness is preventable. The global economic productivity loss due to blindness was estimated to be 19 billion US$ in the year 2000. The initiative “Vision 2020—the right to sight” aims to increase the cataract surgical rate and to eliminate diseases such as trachoma and onchocerciasis as well as avoidable blindness in children. It is planned that blindness in 100 million people can be avoided by the year 2020.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9
Abb. 10
Abb. 11
Abb. 12

Literatur

  1. Bailey R, Lietman T (2001) The safe strategy for the elemination of trachoma by 2020: Will it work? Bull WHO 79:233–236

    CAS  PubMed  Google Scholar 

  2. Belfort R, Muccioli C (1995) Experience of HIV/AIDS and the eye in Brazil, South Amerika. Community Eye Health 8:26–27

    Google Scholar 

  3. Belfort R (2000) The Ophthalmologist and the global impact of the AIDS epidemic LV Edvard Jackson memorial lecture. Am J Ophthalmol 129:1–8

    Article  PubMed  Google Scholar 

  4. Calcutt C, Murray ADN (1998) Untreated essential infantile esotropia: factors affecting the developement of amblyopia. Eye 12:167–172

    PubMed  Google Scholar 

  5. Courtright P, Lewallen S (1998) Ocular manifestations of leprosy. In: Johnson GJ, Minassian DC, Weale R (eds) The epidemiology of eye disease. Chapman and Hall Medical, London

  6. Courtright P, Lewallen S, Tungpakorn N et al. (2001) Cataract in Leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea. Br J Ophthalmol 85:643–647

    Article  CAS  PubMed  Google Scholar 

  7. Dandona L, Williams JD, Williams BC, Rao GN (1998) Population-based assessment of childhood blindness in Southern India. Arch Ophthalmol 116:545–546

    CAS  Google Scholar 

  8. Dawson C, Schachter J (1999) Can blinding trachoma be eliminated worldwide? Arch Ophthalmol 117:974

    CAS  PubMed  Google Scholar 

  9. Foster A (2001) Cataract and „Vision 2020—the right to sight“ initiative. Br J Ophthalmol 85:635–639

    Article  CAS  PubMed  Google Scholar 

  10. Fransen L, Klauß V (1988) Neonatal ophthalmia in the developing world. Int Ophthalmol 11:189

    CAS  PubMed  Google Scholar 

  11. Frick KD, Lietman TM, Holm SO et al. (2001) Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bulletin of the WHO 79:201–207

    CAS  Google Scholar 

  12. Frick KD, Foster A (2003) The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am J Ophthalmol 135:471–476

    Article  PubMed  Google Scholar 

  13. Grehn F (2001) World health problem of glaucoma. J Glaucoma 10:S2–S3

    Article  CAS  PubMed  Google Scholar 

  14. Hero M, Harding SP, Riva CE et al. (1997) Photographic and angiographic characterization of the retina of Keniyan children with severe malaria. Arch Ophthalmol 115:997–1003

    CAS  PubMed  Google Scholar 

  15. Huismans H (1979) Tierische Parasiten des menschlichen Auges. Enke, Stuttgart

  16. Johnson GJ (2000) Improving outcome of cataract surgery in developing countries. Lancet 355:158–159

    Article  CAS  PubMed  Google Scholar 

  17. Jyotirmay B, Madhavan HN, George AE et al. (2000) Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center. Am J Ophthalmol 129:9–15

    Article  PubMed  Google Scholar 

  18. Kapoor H, Chatterjee A, Daniel R, Foster A (1999) Evaluation of visual outcome of cataract surgery in an Indian eye camp. Br J Ophthalmol 83:343–346

    CAS  PubMed  Google Scholar 

  19. Kennedy D (2002) Good news on a tropical disease. Science 296:1365

    Article  CAS  PubMed  Google Scholar 

  20. Kestelyn P, van de Perre P, Rouvroy D et al. (1985) A prospective study of the ophthalmologic findings in the aquired immune deficiency syndrome in Africa. Am J Ophthalmol 100:230–238

    CAS  PubMed  Google Scholar 

  21. Kestelyn P (1999) The epidemiology of CMV retinitis in Africa. Ocular Immunol Inflamm 7:173–177

    Article  CAS  Google Scholar 

  22. Klauß V (1986) Conjunctivitis durch Chlamydien und Parasiten. Fortschr Ophthalmol 83:72

    PubMed  Google Scholar 

  23. Klauss V (2000) Tropische Ophthalmologie. In: Lang W, Löscher T (Hrsg) Tropenmedizin in Klinik und Praxis. Georg Thieme, Stuttgart

  24. Lewallen S (1994) Herpes Zoster Ophthalmicus in Malawi. Ophthalmology 101:1801–1804

    CAS  PubMed  Google Scholar 

  25. Lewallen S, Kumwenda J, Maher D, Harries AD (1994) Retinal findings in Malawian patients with AIDS. Br J Ophthalmol 78:757–759

    CAS  PubMed  Google Scholar 

  26. Lewallen S, Courtright P (1997) HIV and Aids and the Eye in developing countries. Arch Ophthalmol 115:1291–1295

    CAS  PubMed  Google Scholar 

  27. Schaller UC, Klauss V (2001) Is Credé’s prophylaxis still valid? Bulletin of the WHO 79:262–263

    CAS  Google Scholar 

  28. Schaller UC, Walli RK, Mueller AJ, Klauß V (1999) Regression der Zytomegalievirus-Retinitis bei AIDS-Patienten ohne systemische Anti-Zytomegalievirus-Erhaltungstherapie unter hochaktiver antiretroviraler Therapie (HAART). Ophthalmologe 96:829–831

    Article  CAS  PubMed  Google Scholar 

  29. Sommer A (1982) Nutritional blindness—xerophthalmia and keratomalacia. Oxford University Press, London

  30. Sovani I, Humphrey JH, Kuntinalibronto DR et al. (1994) Response of biot’s spot to a single oral 100.000- or 200.000-IU dose of vitamin A. Am J Ophthalmol 118:792–796

    CAS  PubMed  Google Scholar 

  31. Spaide RF, Gaissinger A, Podhorzer JR (1995) Risk factors for cotton-wool spots and for Cytomegalovirus retinitis in patients with human immunodeficiency virus infection. Ophthalmology 102:1860–1864

    CAS  PubMed  Google Scholar 

  32. Srinivasa DK, D’Souza V (1987) Economic aspects of an epidemic of Haemorrhagic conjunctivitis in a rural community. J Epidemiol Com Health 41:79–81

    CAS  Google Scholar 

  33. Tarantola DJ, Mann JM (1996) Global expansion of HIV infection and AIDS. Hosp Pract (Off Ed) 31:63–79

    Google Scholar 

  34. Umeh RE, Umeh OC (1997) Causes and visual outcome of childhood eye injuries in Nigeria. Eye 11:489–495

    PubMed  Google Scholar 

  35. Waddel KM, Lewallen S, Lucas SB et al. (1996) Carcinoma of the conjunctiva and HIV infection in Unganda and Malawi. Br J Ophthalmol 80:503–508

    CAS  PubMed  Google Scholar 

  36. West S, Sommer A (2001) Prevention of blindness and priorities for the future. Bull WHO 79:244–248

    CAS  PubMed  Google Scholar 

  37. Zumla A, Sawa D, Wheeler RB et al. (1991) Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg 85:227–229

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Keine Angaben

Author information

Authors and Affiliations

  1. Augenklinik der Ludwig Maximilians Universität, München

    V. Klauß

  2. Department of Ophthalmology, Kenyatta National Hospital, University of Nairobi, Nairobi, Kenia

    U. C. Schaller

  3. Augenklinik der Ludwig Maximilians Universität, Mathildenstraße 8, 80336 , München

    V. Klauß

Authors
  1. V. Klauß
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. C. Schaller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Klauß.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klauß, V., Schaller, U.C. Tropenophthalmologie—Prävention und Therapie. Ophthalmologe 101, 741–765 (2004). https://doi.org/10.1007/s00347-004-1039-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-004-1039-8

Schlüsselwörter

Keywords

Search

Navigation